We have previously shown that overexpression of either NOD1 and NOD2 innate immune receptors impacts cell proliferation and clonogenic potential of the triple negative, breast cancer-derived Hs578T cell line [46]. This evidence concerns the gene NOD2 and breast carcinoma.